Things are looking good for German Biotechs! At least, this is what the general mood at the international congress organized by the IZB on July 16th and 17th 2015 in Martinsried, near Munich, reflected. A bunch of international investors and decision makers gathered to show that the sector is picking up momentum again in Germany!
The Innovation and Startup Center for Biotechnology (IZB) on the Martinsried Campus, organized a two-day congress with top-ranking Venture capitalists, influential politicians and successful CEOs from biotech companies like Morphosys or Evotec.
A sign of the upward trend, Venture capitalists, like TVM, whose last investment in Germany goes back to 2009, are once more showing targeted commitment.
“In the next few weeks we will announce an investment in Munich that will be around 22 million Euro”, said Hubert Birner from TVM Capital.
The money stems from their newly closed fund in 2014. Altogether a total volume of nearly 250 million dollars is available,